Prognostic analysis of early-stage squamous cell carcinoma of the vulva

Table 1 Univariate analysis of overall survival and progression-free survival time

Risk factors	Overall survival			Progression-free survival
Risk factors	Number of patients	OS at five years (%)	Log-rankPvalue	PFS at five years (%)	Log-rankPvalue
Age (years)			0.661		0.941
≤50	6	83.3		83.3
50 to 60	14	91.7		91.7
>60	15	78.6		71.4
FIGO stage			0.733		0.637
1a	5	100		100
1b	30	81.5		77.8
Tumor location			0.047		0.039
Lateral	9	64.8		66.7
Medial	26	87.0		87
Grade			0.493		0.458
I	26	84.0		84.0
II	7	62.5		83.3
III	2	50.0		50.0
Morphology			0.028		0.042
cauliflower	26	91.3		87.0
nodular	9	66.7		62.5
Lymph node clinical state			0.014		0.022
not increased and active	16	73.3		66.7
increased and hard	17	92.9		92.9
syncretic	2	50.0		50.0
invasion depth (mm)			0.842		0.918
≤1	5	100		100
1 to 4	10	80.0		70.0
5 to 7	10	62.5		62.5
>7	10	75.0		75.0
Surgical treatment			0.005		0.003
Local excision	2	83.9		83.9
Radical vulvectomy and en bloc resection of inguinofemoral lymph nodes	12	81.8		72.7
Radical vulvectomy and en bloc resection of inguinofemoral and pelvic lymph nodes	21	50.0		50.0

FIGO, International Federation of Gynecology and Obstetrics; OS, overall survival; PFS, progression-free survival.

ISSN: 1477-7819